BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7445020)

  • 1. Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    Thymus; 1980 Jan; 1(4-5):195-204. PubMed ID: 7445020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide.
    Laghi Pasini F; Auteri A; Ceccatelli L; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):316-22. PubMed ID: 7018516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.
    Verhaegen H; De Cock W; De Cree J
    Clin Exp Immunol; 1977 Aug; 29(2):311-5. PubMed ID: 908176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of levamisole on autologous rosette-forming cells in nude mice.
    Van Wauwe J; Van Nijen G
    Clin Exp Immunol; 1977 Dec; 30(3):465-8. PubMed ID: 304789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levamisole on spontaneous rosette-forming cells in murine spleen.
    van Ginckel RF; Hoebeke J
    Eur J Immunol; 1976 Apr; 6(4):305-7. PubMed ID: 1086780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division.
    Denes L; Szende B; Ember J; Major J; Szporny L; Hajos G; Nyeki O; Schon I; Lapis K; Kisfaludy L
    Immunopharmacol Immunotoxicol; 1987; 9(1):1-18. PubMed ID: 3330094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thymopoietin pentapeptide (TP5) on autoimmunity. I. TP5 suppression of induced erythrocyte autoantibodies in C3H mice.
    Lau CY; Freestone JA; Goldstein G
    J Immunol; 1980 Oct; 125(4):1634-8. PubMed ID: 6967912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.
    Goldstein G; Scheid MP; Boyse EA; Schlesinger DH; Van Wauwe J
    Science; 1979 Jun; 204(4399):1309-10. PubMed ID: 451537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunokinetics of a single dose of thymopoietin pentapeptide.
    Di Perri T; Laghi Pasini F; Auteri A
    J Immunopharmacol; 1980; 2(4):567-72. PubMed ID: 7009760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
    Modai D; Peller S; Weissgarten J; Shaked U; Kaufman S
    Isr J Med Sci; 1981 Dec; 17(12):1115-8. PubMed ID: 7327910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes).
    Dammacco F; Miglietta A; Bonomo L
    Ric Clin Lab; 1977; 7(4):343-53. PubMed ID: 307801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.
    De Cock W; De Cree J; Verhaegen H
    Immunology; 1978 Aug; 35(2):223-7. PubMed ID: 312252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.
    Jackson TM; Zaman SN
    Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L; Szende B; Hajós G; Szporny L; Lapis K
    Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.